Sidhu Pharma Labs Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 07-01-2025
- Paid Up Capital ₹ 2.00 M
as on 07-01-2025
- Company Age 19 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.00 M
as on 07-01-2025
- Revenue 25.71%
(FY 2022)
- Profit 33.24%
(FY 2022)
- Ebitda 17.44%
(FY 2022)
- Net Worth 5.40%
(FY 2022)
- Total Assets -10.46%
(FY 2022)
About Sidhu Pharma Labs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹3.00 M.
Shankar and Sankar Siddharth serve as directors at the Company.
- CIN/LLPIN
U24233TN2005PTC056881
- Company No.
056881
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jul 2005
- Date of AGM
18 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Nagapattinam, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sidhu Pharma Labs Private Limited offer?
Sidhu Pharma Labs Private Limited offers a wide range of products and services, including Amoxicillin drugs, Amoxicillin Potassium Clavulanate Tablet, Anti Inflammatory Drugs, Deflazacort Tablets, Antipyretic Medication, Paracetamol Tablets, Pharmaceutical Tablets, Cough Syrup, Pharmaceutical Syrup, Multivitamin Syrup & Drops.
Who are the key members and board of directors at Sidhu Pharma Labs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shankar  | Managing Director | 12-Jul-2005 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sankar Siddharth | Director | 22-Dec-2015 | Current |
Financial Performance of Sidhu Pharma Labs.
Sidhu Pharma Labs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 25.71% increase. The company also saw a substantial improvement in profitability, with a 33.24% increase in profit. The company's net worth moved up by a moderate rise of 5.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sidhu Pharma Labs?
In 2021, Sidhu Pharma Labs had a promoter holding of 75.00% and a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Clan Promoters Private LimitedActive 9 years 4 monthsShankar and Sankar Siddharth are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 27 Jul 2015 | ₹3.00 M | Open |
How Many Employees Work at Sidhu Pharma Labs?
Unlock and access historical data on people associated with Sidhu Pharma Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sidhu Pharma Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sidhu Pharma Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
